Series D - Aura Biosciences

Series D - Aura Biosciences

Investment Firm

Overview

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

Announced Date

Apr 02, 2019

Funding Type

Series D

Highlights

Location

United States, North America

Social

Investor Lead

Medicxi

Medicxi

Medicxi is a early_stage_venture and seed firm.

Participant Investors

1

Investor Name
Participant InvestorMedicxi

Round Details and Background

Aura Biosciences raised $40000000 on 2019-04-02 in Series D

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

Company Funding History

15

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 08, 2014
Debt Financing - Aura Biosciences
-1.3M
Dec 26, 2012
Venture Round - Aura Biosciences
-3.2M
Sep 01, 2010
Series A - Aura Biosciences
-1.4M
Aug 26, 2011
Series A - Aura Biosciences
-3.0M

Recent Activity

There is no recent news or activity for this profile.